Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Dowling

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Soft Matter|September 13, 2018
Sequential deposition of microdroplets on patterned surfacesPallav Kant, Andrew L Hazel, Mark Dowling, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
An Alternative DNA Endonuclease Activity is Associated with the LINE-1 ORF2-encoded ProteinMitsuhiro Nakamura, Huira C Kopera, Mark Dowling, et al.
Leukemia & Lymphoma|October 25, 2022
Acute kidney injury in patients receiving high-dose etoposide phosphate as conditioning prior to hematopoietic stem cell transplantation in hematologic malignancies may be associated with elevated body mass indexTamasine Stewart, Mark Dowling, Brett Janson, et al.
RNA (New York, N.Y.)|January 8, 2023
In vivo PIWI slicing in mouse testes deviates from rules established in vitroMark Dowling, David Homolka, Nicole Raad, et al.
Andrology|January 10, 2023
Intermitochondrial cement (IMC) harbors piRNA biogenesis machinery and exonuclease domain-containing proteins EXD1 and EXD2 in mouse spermatocytesOpeyemi Olotu, Mark Dowling, David Homolka, et al.
British Journal of Haematology|October 27, 2024
Seropositivity against vaccine preventable infections in the early post chimeric antigen receptor T-cell period: Preservation of vaccine-associated antibodies between 0 and 6 monthsGemma K Reynolds, Emily Klimevski, Natalie R Saunders, et al.
Expert Review of Hematology|August 1, 2025
Cognitive impairment in hematology patients planned for chimeric antigen receptor T-cell therapyValeriya Kuznetsova, Hannah Rosenfeld, Carmela Sales, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2020
Development of autotaxin inhibitors: A series of tetrazole cinnamidesChristopher G Thomson, Darren Le Grand, Mark Dowling, et al.
BMJ Neurology Open|September 19, 2024
Neuropsychological outcomes of patients with haematological malignancies undergoing chimeric antigen receptor T-cell therapy: protocol for a prospective studyValeriya Kuznetsova, Harsh Oza, Hannah Rosenfeld, et al.
BMJ Neurology Open|March 25, 2026
Neurological implications of chimeric antigen receptor-T cell therapyDaniel G Raffoul, Izanne Roos, Matthias Mulazzani, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Soft Matter|September 13, 2018
Sequential deposition of microdroplets on patterned surfacesPallav Kant, Andrew L Hazel, Mark Dowling, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
An Alternative DNA Endonuclease Activity is Associated with the LINE-1 ORF2-encoded ProteinMitsuhiro Nakamura, Huira C Kopera, Mark Dowling, et al.
Leukemia & Lymphoma|October 25, 2022
Acute kidney injury in patients receiving high-dose etoposide phosphate as conditioning prior to hematopoietic stem cell transplantation in hematologic malignancies may be associated with elevated body mass indexTamasine Stewart, Mark Dowling, Brett Janson, et al.
RNA (New York, N.Y.)|January 8, 2023
In vivo PIWI slicing in mouse testes deviates from rules established in vitroMark Dowling, David Homolka, Nicole Raad, et al.
Andrology|January 10, 2023
Intermitochondrial cement (IMC) harbors piRNA biogenesis machinery and exonuclease domain-containing proteins EXD1 and EXD2 in mouse spermatocytesOpeyemi Olotu, Mark Dowling, David Homolka, et al.
British Journal of Haematology|October 27, 2024
Seropositivity against vaccine preventable infections in the early post chimeric antigen receptor T-cell period: Preservation of vaccine-associated antibodies between 0 and 6 monthsGemma K Reynolds, Emily Klimevski, Natalie R Saunders, et al.
Expert Review of Hematology|August 1, 2025
Cognitive impairment in hematology patients planned for chimeric antigen receptor T-cell therapyValeriya Kuznetsova, Hannah Rosenfeld, Carmela Sales, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2020
Development of autotaxin inhibitors: A series of tetrazole cinnamidesChristopher G Thomson, Darren Le Grand, Mark Dowling, et al.
BMJ Neurology Open|September 19, 2024
Neuropsychological outcomes of patients with haematological malignancies undergoing chimeric antigen receptor T-cell therapy: protocol for a prospective studyValeriya Kuznetsova, Harsh Oza, Hannah Rosenfeld, et al.
BMJ Neurology Open|March 25, 2026
Neurological implications of chimeric antigen receptor-T cell therapyDaniel G Raffoul, Izanne Roos, Matthias Mulazzani, et al.
Pageof 2